- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03706378
Food Modification to Alter Glycaemia and Insulinaemia
May 10, 2019 updated by: JeyaKumar Henry, Clinical Nutrition Research Centre, Singapore
The study specifically aims to determine glycemic and insulinemic response of added low GI ingredients, beta-glucan, resistant starch and isomaltulose to foods.
Study Overview
Status
Completed
Conditions
Detailed Description
There will be a total of 9 test sessions and each session will last up to 3 hours.
At each test session, the following procedures will be performed: two finger-prick blood samples, five minutes apart to measure baseline blood glucose and insulin concentrations.
Subject will be served the test food and to consume within15 minutes.
Following the test meal, blood samples will be collected at the following time points: 15, 30, 45, 60, 90, 120, 150 and 180min for glucose measurements and insulin measurements will be collected at 30, 60, 90, 120, 150 and 180min.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy Males
- Chinese ethnicity
- Age ≥21 and ≤ 40 years
- Body mass index between 18.5 to 25 kg/m2
- Normal blood pressure ≤140/90 mmHg
- Fasting blood glucose <6.0 mmol/L
- In general good health
Exclusion Criteria:
- Current smoker
- Have metabolic diseases (such as diabetes, hypertension etc)
- Have glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
- Have medical conditions and/or taking medications known to affect glycaemia (glucocorticoids, thyroid hormones, thiazide diuretics)
- Have an ongoing infection or currently undergoing treatment at the time of screening
- Have known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
- Have active Tuberculosis (TB) or currently receiving treatment for TB
- Intolerances or allergies to any foods
- Partake in sports at the competitive and/or endurance levels
- Intentionally restrict food intake
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Glucose Reference 1
50g glucose dissolve in 250 ml of water
|
Glucose contains 50g of available carbohydrates
|
|
Other: Glucose Reference 2
50g glucose dissolve in 250 ml of water
|
Glucose contains 50g of available carbohydrates
|
|
Other: Glucose Reference 3
50g glucose dissolve in 250 ml of water
|
Glucose contains 50g of available carbohydrates
|
|
Experimental: Wheat Yellow Noodle
Boiled 170.6g of wheat yellow noodle
|
Wheat Yellow Noodle will contain 50g of available carbohydrate
|
|
Experimental: Beta-glucan Yellow Noodle
Boiled 230.4g of beta-glucan yellow noodle.
|
Beta-glucan yellow noodle will contain 50g of available carbohydrate
|
|
Experimental: Rice Roll
Steamed 197.6g of rice roll
|
Rice Roll will contain 50g of available carbohydrate
|
|
Experimental: Rice Roll with resistant starch
Steamed 232.6g of rice roll fortified with resistant starch
|
Rice Roll fortified with resistant starch will contain 50g of available carbohydrate
|
|
Experimental: Sucrose jelly
Jelly made with 25g of sucrose and 48g of wheat white bread
|
Jelly and bread will contain 50g of available carbohydrate.
The jelly will contain 25g of sucrose
|
|
Experimental: Isomaltulose jelly
Jelly made with 25g of isomaltulose and 48g of wheat white bread
|
Jelly and bread will contain 50g of available carbohydrate.
The jelly will contain 25g of Isomaltulose
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose
Time Frame: up to 180 minutes
|
Blood glucose will be collected using finger prick method and analysed using Hemocue analyser
|
up to 180 minutes
|
|
Insulin
Time Frame: up to 180 minutes
|
Blood glucose will be collected using finger prick method and analysed using Cobas analyser
|
up to 180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 18, 2017
Primary Completion (Actual)
April 4, 2019
Study Completion (Actual)
April 4, 2019
Study Registration Dates
First Submitted
October 11, 2018
First Submitted That Met QC Criteria
October 11, 2018
First Posted (Actual)
October 16, 2018
Study Record Updates
Last Update Posted (Actual)
May 13, 2019
Last Update Submitted That Met QC Criteria
May 10, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2017/00538
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
Clinical Trials on Glucose Reference 1
-
Clinical Nutrition Research Centre, SingaporeBarilla Singapore Pte LtdCompleted
-
Clinical Nutrition Research Centre, SingaporeCompleted
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes Mellitus, Type 2 | PreDiabetesSingapore
-
Institut fur Diabetes Karlsburg GmbHCompleted
-
Institut fur Diabetes Karlsburg GmbHCompleted
-
Institut fur Diabetes Karlsburg GmbHAktivmed GmbH; Beurer GmbH; IME-DC GmbH; Medisana GmbHCompleted
-
Mondelēz International, Inc.Glycemic Index Laboratories, IncCompleted
-
Institut fur Diabetes Karlsburg GmbHHangzhou Sejoy Electronics & Instrument Co., ltd. Joytech Healthcare Co.,...Completed
-
Institut fur Diabetes Karlsburg GmbHBeurer GmbHCompletedDiabetes MellitusGermany